London close: Stocks rise as US PCE inflation slows
(Sharecast News) - London stocks closed higher on Friday as investors digested a slowdown in the Federal Reserve's preferred inflation measure. The FTSE 100 gained 0.43% to reach 8,320.76, while the ...
Bristol-Myers Squibb: Hold Rating Amid New Schizophrenia Drug Launch and Patent Expiries
Analyst Evan Seigerman from BMO Capital maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report) and increased the price ...
kalkinemedia6h
PureTech Health Celebrates FDA Approval of Cobenfy: A Milestone in Schizophrenia Treatment
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) has achieved a significant milestone with the FDA's recent approval of Cobenfy ...
FTSE 250 movers: Burberry gains on China boost
Stocks in China got a boost after the central bank cut its main policy rate and financial institutions’ reserve requirement ratio in a bid to boost lending. The People’s Bank of China cut the ...
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb's Cobenfy As First New Class Of Treatment In More Than 3 Decades
Cobenfy (xanomeline and trospium chloride, KarXT), an oral medication for schizophrenia in adults. Bristol-Myers added the ...
MT Newswires on MSN8h
Bristol-Myers Squibb Gets FDA Approval for Schizophrenia Drug
Bristol-Myers Squibb (BMY) shares rose early Friday as the biopharmaceutical company obtained approval from the US Food and Drug Administration for its Cobenfy drug to treat schizophrenia in adults.
PureTech Health celebrates KarXT approval by FDA for schizophrenia
PureTech Health PLC on Friday said KarXT has received US Food & Drug Administration approval for treating schizophrenia. The Boston, Massachusetts-based biotechnology company said the milestone ...
French inflation ‘crash’ raises pressure for interest rate cuts
Christine Lagarde is under pressure to ramp up the pace of interest rate cuts in the eurozone after French and Spanish ...
Exchange 4 Media13h
Mondelēz joins forces with Accenture & Publicis Groupe to advance AI marketing
Mondelēz International has announced the launch of a new platform designed to improve its global marketing capabilities while optimizing consumer experiences through expanded use of artificial ...
Exchange 4 Media13h
OMD India clocks new business wins worth $54 million in H1
COMvergence has released its New Business Barometer report for India, assessing more than 1,740 media account moves and ...
Buy14h
LONDON BRIEFING: FTSE 100 called up, Merchants Trust beats benchmark
In company news, PureTech Health reported US Food & Drug Administration approval for its schizophrenia drug, and abrdn Property Income Trust agreed to sell a subsidiary for GBP351 million. Here is ...
FDA Approves KarXT To Treat Schizophrenia; PureTech Health Gets $29 Mln Milestone Payment
This approval triggers 2 milestone payments totaling $29 million, as per agreements with Royalty Pharma and PureTech's founded entity, Karuna Therapeutics, which was acquired by Bristol Myers Squibb ...